Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these processes. RESEARCH DESIGN AND METHODS: We examined fatty acid and glucose metabolism and gene expression in cultured human skeletal muscle cells from control and type 2 diabetic individuals after 4 days of preincubation with EPA or TTA. RESULTS: Type 2 diabetes myotubes exhibited reduced formation of CO(2) from palmitic acid (PA), whereas release of beta-oxidation products was unchanged at baseline but significantly increased with respect to control myotubes after preincubation with TTA and EPA. Preincubation with TTA enhanced both complete (CO2) and beta-oxidation of palmitic acid, whereas EPA increased only beta-oxidation significantly. EPA markedly enhanced triacylglycerol (TAG) accumulation in myotubes, more pronounced in type 2 diabetes cells. TAG accumulation and fatty acid oxidation were inversely correlated only after EPA preincubation, and total level of acyl-CoA was reduced. Glucose oxidation (CO2 formation) was enhanced and lactate production decreased after chronic exposure to EPA and TTA, whereas glucose uptake and storage were unchanged. EPA and especially TTA increased the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation. CONCLUSIONS: Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes is caused by disturbances downstream of fatty acid beta-oxidation; 2) EPA promoted accumulation of TAG, enhanced beta-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG. 1. Palmitate uptake and oxidation. Differentiated myotubes from type 2 diabetic or control subjects were preincubated with 40 μmol/l BSA, 100 μmol/l oleic acid, 100 μmol/l TTA, or 100 μmol/l EPA for 4 days and incubated with 0.6 mmol/l [1-14C]PA for 4 h. The panels show palmitate uptake, which is the sum of total recovered CO2, ASMs, and total lipids (A); oxidation to CO2 (B); CO2 from palmitic acid as percentage of total oxidation (C). Results present means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data. T2D, type 2 diabetes.](https://figures.cochat.ai/paper-figures/2c2dced4d81c4e6689a659972b457654/fatty-acid-incubation-of-myotubes-from-humans-with-type-2-diabetes-leads-to-figure-1.jpg)
![FIG. 2. Palmitate-derived ASMs release to the medium. Differentiated myotubes from type 2 diabetes or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with 0.6 mmol/l [1-14C]PA ± 1 μmol/l insulin for 4 h. The panels show ASMs released from the cells, derived from 14C–palmitic acid without (A) and with (B) 1 μmol/l insulin. Results represent means ± SE (n = 6–7). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.](https://figures.cochat.ai/paper-figures/02c6a20379f448eb808b88b20bf8680b/fatty-acid-incubation-of-myotubes-from-humans-with-type-2-diabetes-leads-to-figure-2.jpg)
![FIG. 3. Changes in TAG accumulation from 14C–palmitic acid relative to baseline (A) and negative correlation between changes in 14C–palmitic acid oxidation and TAG accumulation after preincubation with EPA (B). Differentiated myotubes from type 2 diabetic or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with [1-14C]PA (0.6 mmol/l) for 4 h. The panels show changes in 14C–palmitic acid–derived TAGs as percentage of baseline (BSA) (A) and a negative correlation between changes in total 14C–palmitic acid oxidation and TAG accumulation in myotubes preincubated with EPA (r = −0.69, P < 0.001). Results represent means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.](https://figures.cochat.ai/paper-figures/a9a024e0b9a04383b905c1376be04668/fatty-acid-incubation-of-myotubes-from-humans-with-type-2-diabetes-leads-to-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Wensaas and colleagues (2008) also observed a marked increase in TAG synthesis following EPA treatment in isolated skeletal muscle myotubes and this effect was more pronounced in myotubes isolated from T2D individuals [133].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [133]
In the citing paper
“EPA also reduced the amount of C:18-2 CoA beyond that of control and again this effect was more pronounced in T2D myotubes.”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“PGC1 is an important regulator of muscle oxidative capacity, mitochondrial content, and fiber type (31,32), and insulin resistance may be negatively associated with PGC1 expression in skeletal muscle (33,34).”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“In support for this, several studies have suggested a mitochondrial dysfunction in the etiology of insulin resistance and type 2 diabetes (4,6,28).”
BackgroundTriglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Increased levels of acyl-CoA and especially C18:2-CoA have been associated with insulin resistance (42,43).”
BackgroundSkeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179 · cited 1×
“The increased deposition of intramyocellular TAG (imTAG) has received special interest, because several studies have demonstrated a positive association between insulin resistance and imTAG storage (1,2).”
BackgroundSkeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Cited by
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
Kalupahana, N. S., Claycombe, K., Newman, S. J., Stewart, T., Siriwardhana, N., Matthan, N., Lichtenstein, A. H., & Moustaid-Moussa, N. (2010) · The Journal of Nutrition · doi:10.3945/jn.110.125732 · Cited by 301
Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome
Schreurs, M., Kuipers, F., & Van Der Leij, F. R. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00642.x · Cited by 296
“Although obesity is associated with increased lipid oxidation (44), accumulation of triglycerides in muscle tissue in type 2 diabetes has been observed (45).”
BackgroundSeifert, E. L., Estey, C., Xuan, J. Y., & Harper, M.-E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026203 · Cited by 280
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?
Ademowo, O. S., Dias, H. K. I., Burton, D. G. A., & Griffiths, H. R. (2017) · Biogerontology · doi:10.1007/s10522-017-9710-z · Cited by 184
Henique, C., Mansouri, A., Fumey, G., Lenoir, V., Girard, J., Bouillaud, F., Prip-Buus, C., & Cohen, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170431 · Cited by 159
Lipke, K., Kubis-Kubiak, A., & Piwowar, A. (2022) · Cells · doi:10.3390/cells11050844 · Cited by 182
Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation
Pettersen, I. K. N., Tusubira, D., Ashrafi, H., Dyrstad, S. E., Hansen, L., Liu, X., Nilsson, L. I. H., Løvsletten, N. G., Berge, K., Wergedahl, H., et al. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.009 · Cited by 177
Skeletal muscle energy metabolism in obesity
Mengeste, A. M., Rustan, A. C., & Lund, J. (2021) · Obesity · doi:10.1002/oby.23227 · Cited by 141
Self-citationWatt, M. J., & Hoy, A. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2011 · Cited by 142
Hong, F., Xu, P., & Zhai, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082189 · Cited by 139
Bosma, M., Kersten, S., Hesselink, M. K. C., & Schrauwen, P. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.003 · Cited by 156
Nutritional influences on age-related skeletal muscle loss
Welch, A. A. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113003698 · Cited by 133
“Moreover, in vitro studies have found EPA increases fatty acid oxidation in myotubules((212,213)).”
BackgroundAre cultured human myotubes far from home?
Aas, V., Bakke, S. S., Feng, Y., Kase, E. T., Jensen, J., Bajpeyi, S., Thoresen, G. H., & Rustan, A. C. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1655-1 · Cited by 138
Mitochondrial lipid oxidation is impaired in cultured myotubes from obese humans
Boyle, K. E., Zheng, D., Anderson, E. J., Neufer, P. D., & Houmard, J. A. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.201 · Cited by 88
Yang, Y., Andrews, M. C., Hu, Y., Wang, D., Yu, Q., Zhu, Y., Ni, H., & Ling, W. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf201079h · Cited by 90
Metabolic switching of human myotubes is improved by n-3 fatty acids
Hessvik, N. P., Bakke, S. S., Fredriksson, K., Boekschoten, M. V., Fj⊘rkenstad, A., Koster, G., Hesselink, M. K., Kersten, S., Kase, E. T., Rustan, A. C., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003319 · Cited by 71
Self-citationCastillero, E., Martín, A. I., López-Menduiña, M., Villanúa, M. A., & López-Calderón, A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00388.2009 · Cited by 53
“A similar effect of EPA was recently described in diabetic myotubes, where EPA also improved insulin resistance and fatty acid handling in type 2 diabetes skeletal muscle (47).”
Gaster, M., Nehlin, J. O., & Minet, A. D. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.656653 · Cited by 63
Nutrition and sarcopenia: A review of the evidence of nutritional influences
Abiri, B., & Vafa, M. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1412940 · Cited by 64
Chronic hyperglycemia reduces substrate oxidation and impairs metabolic switching of human myotubes
Aas, V., Hessvik, N. P., Wettergreen, M., Wensaas, A. J., Hallén, S., Thoresen, G. H., & Rustan, A. C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.014 · Cited by 59
“Decreased complete oxidation in combination with increased incomplete oxidation of fatty acids as observed after chronic HG exposure has also been reported to occur in myotubes from obese type 2 diabetic individuals [40].”
BackgroundMarafie, S. K., ALSHAWAF, E. M. M., Abubaker, J. A., & Arefanian, H. (2019) · Biological Research · doi:10.1186/s40659-019-0253-4 · Cited by 53
Nehlin, J. O., Just, M., Rustan, A. C., & Gaster, M. (2011) · Biogerontology · doi:10.1007/s10522-011-9336-5 · Cited by 66
Minet, A. D., & Gaster, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.115 · Cited by 48
Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism
Lund, J., Rustan, A. C., Løvsletten, N. G., Mudry, J. M., Langleite, T. M., Feng, Y. Z., Stensrud, C., Brubak, M. G., Drevon, C. A., Birkeland, K. I., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175441 · Cited by 43
Hoffmann, C., Höckele, S., Kappler, L., de Angelis, M. H., Häring, H., & Weigert, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18658-3 · Cited by 54
Sergi, D., Luscombe‐Marsh, N. D., Naumovski, N., Abeywardena, M. Y., & O’Callaghan, N. J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.663838 · Cited by 46
“However, despite this being supported by previous evidence (34), it remains to be fully investigated by directly quantifying fatty acid βoxidation (61) or tracking fatty acid metabolic fate by lipidomics (62).”
BackgroundBakke, S. S., Moro, C., Nikolić, N., Hessvik, N. P., Badin, P.-M., Lauvhaug, L., Fredriksson, K., Hesselink, M. K. C., Boekschoten, M. V., Kersten, S., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.001 · Cited by 50
Stephens, F. B., Mendis, B., Shannon, C. E., Cooper, S., Ortori, C. A., Barrett, D. A., Mansell, P., & Tsintzas, K. (2014) · Clinical Science · doi:10.1042/cs20140031 · Cited by 35
Corpeleijn, E., Hessvik, N. P., Bakke, S. S., Levin, K., Blaak, E. E., Thoresen, G. H., Gaster, M., & Rustan, A. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00187.2010 · Cited by 35
Liang, H., Zhong, Y., Zhou, S., & Li, Q. Q. (2011) · PubMed · Cited by 44
Hessvik, N. P., Bakke, S. S., Smith, R., Ravna, A. W., Sylte, I., Rustan, A. C., Thoresen, G. H., & Kase, E. T. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.10.006 · Cited by 42
Gjelstad, I. M. F., Haugen, F., Gulseth, H. L., Norheim, F., Jans, A., Bakke, S. S., Raastad, T., Tjønna, A. E., Wisløff, U., Blaak, E. E., et al. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.630009 · Cited by 42
“vastus lateralis) of eight obese subjects with type 2 diabetes (T2D) and eight age- and BMI-matched control subjects (Wensaas et al., 2009).”
BackgroundLiu, Y., Wang, J., Zhou, X., Cao, H., Zhang, X., Huang, K., Li, X., Yang, G., & Shi, X. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.09.037 · Cited by 29
Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects
Gaster, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.102 · Cited by 32
Maternal metabolic health drives mesenchymal stem cell metabolism and infant fat mass at birth
Erickson, M. L., Patinkin, Z. W., Duensing, A. M., Dabelea, D., Redman, L. M., & Boyle, K. E. (2021) · JCI Insight · doi:10.1172/jci.insight.146606 · Cited by 29
“16 myotubes cultured from adults with established obesity are unable to robustly increase FAO rates 284 when challenged with excess fatty acids (14-17, 26).”
BackgroundInsulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
Eriksen, M., Pørneki, A. D., Skov, V., Burns, J. S., Beck-Nielsen, H., Glintborg, D., & Gaster, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014469 · Cited by 28
Bakke, S. S., Feng, Y., Nikolić, N., Kase, E. T., Moro, C., Stensrud, C., Damlien, L., Ludahl, M. O., Sandbu, R., Solheim, B. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119556 · Cited by 30
Liu, Z., Shang, Q., Li, H., Fang, D., Li, Z., Huang, Y., Zhang, M., Ko, K. M., & Chen, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154988 · Cited by 24
Zanella, L., & Vianello, F. (2023) · Nutraceuticals · doi:10.3390/nutraceuticals3010010 · Cited by 25
Huang, H., Aminian, A., Hassan, M., Dan, O., Axelrod, C. L., Schauer, P. R., Brethauer, S. A., & Kirwan, J. P. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03800-z · Cited by 22
Sergi, D., Luscombe‐Marsh, N. D., Heilbronn, L. K., Birch‐Machin, M. A., Naumovski, N., Lionetti, L., Proud, C. G., Abeywardena, M. Y., & O’Callaghan, N. J. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa430 · Cited by 19
Løvsletten, N. G., Bakke, S. S., Kase, E. T., Ouwens, D. M., Thoresen, G. H., & Rustan, A. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208048 · Cited by 19
Energy metabolism in skeletal muscle cells from donors with different body mass index
Katare, P. B., Dalmao‐Fernández, A., Mengeste, A. M., Hamarsland, H., Ellefsen, S., Bakke, H. G., Kase, E. T., Thoresen, G. H., & Rustan, A. C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.982842 · Cited by 18
Reduced TCA Flux in Diabetic Myotubes: Determined by Single Defects?
Gaster, M. (2012) · Biochemistry Research International · doi:10.1155/2012/716056 · Cited by 16
“Hindawi Publishing Corporation Biochemistry Research International Volume 2012, Article ID 716056, 6 pages doi:10.1155/2012/716056”
BackgroundInfluentialMinet, A. D., & Gaster, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.028 · Cited by 14
Leung, C. M., Ong, L. J. Y., Kim, S., & Toh, Y. (2022) · Organs-on-a-Chip · doi:10.1016/j.ooc.2022.100021 · Cited by 14
Metabolic switching of human skeletal muscle cells in vitro
Thoresen, G. H., Hessvik, N. P., Bakke, S. S., Aas, V., & Rustan, A. C. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.017 · Cited by 24
Polyunsaturated Fatty Acids in Pregnancy and Metabolic Syndrome: A Review
Poniedziałek‐Czajkowska, E., Mierzyński, R., Kimber-Trojnar, Ż., Leszczyńska‐Gorzelak, B., & Oleszczuk, J. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140330195614 · Cited by 13
Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes
Gaster, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.102 · Cited by 14
You, Y., Ni, H., Ma, Q., Jiang, L., Cai, J., He, W., Lin, X., Li, K., Wang, Z., Yan, W., et al. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00391-w · Cited by 15
Minet, A. D., & Gaster, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1384 · Cited by 9
Ghnaimawi, S., Rebello, L., Baum, J., & Huang, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249438 · Cited by 9
Developmental challenges in infants who are HIV-exposed uninfected
Ntuli, L., Mtshali, A., Mzobe, G. F., Pillay, N., Happel, A., & Ngcapu, S. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106078 · Cited by 7
Lund, J., Stensrud, C., Rajender, Bohov, P., Thoresen, G. H., Berge, R. K., Wright, M., Kamal, A., Rustan, A. C., Miller, A. D., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.01.045 · Cited by 6
Concurrent EPA and DHA Supplementation Impairs Brown Adipogenesis of C2C12 Cells
Ghnaimawi, S., Baum, J., Liyanage, R., & Huang, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00531 · Cited by 7
Yoon, J., Park, M., & Lee, H. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70425 · Cited by 4
Lucchinetti, E., Lou, P., Hersberger, M., Clanachan, A. S., & Zaugg, M. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004838 · Cited by 4
Covington, J. D., Myland, C. K., Rustan, A. C., Ravussin, É., Smith, S. R., & Bajpeyi, S. (2015) · Obesity · doi:10.1002/oby.21192 · Cited by 6
Re-esterified DHA improves ventilatory threshold 2 in competitive amateur cyclists
Ávila-Gandía, V., Torregrosa-García, A., Luque-Rubia, A. J., Abellán-Ruiz, M. S., Victoria‐Montesinos, D., & López-Román, F. J. (2020) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00379-0 · Cited by 6
Dietary Fat Composition and Age-Related Muscle Loss
Welch, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2769-7_6 · Cited by 1
Metabolic Inflexibility in Skeletal Muscle With Obesity
Boyle, K. E. (2009) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Boyle, K. E., & Friedman, J. E. (2011) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539511000118
Weber, T. M. (2013) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Huang, T., Zheng, J., Mojica, N., & Li, D. (2013) · Current Proteomics · doi:10.2174/15701646112099990004
Effekter og metabolisme av ulike fettsyrer i humane skjelettmuskelceller i kultur
Lauvhaug, L. (2011) · NVA (Nasjonalt vitenarkiv) · Cited by 1
Attia, R. R. (2009) · doi:10.21007/etd.cghs.2009.0019
“Elevated gluconeogenesis and disturbance in fatty acid metabolism are observed in metabolic diseases as diabetes, obesity and hyperthyroidism (Basu et al., 2005; Baxter et al., 2004; Chevalier et al., 2006; Crunkhorn & Patti, 2008; Kabir et al., 2005; Wensaas et al., 2009).”
Jeromson, S. (2017) · Stirling Online Research Repository (University of Stirling)
Current literature in diabetes
(2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1034 · Cited by 1
You, Y., Ni, H., Ma, Q., Jiang, L., Cai, J., He, W., Lin, X., Li, K., Wang, Z., Yan, W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3954951/v1
Nundal, C. H., Tungland, S. L., Bakke, H. G., Bohov, P., Aloysius, T. A., Rustan, A. C., Bjørndal, B., Brønstad, A., Øyen, J., Brandt, S., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1611166
Metadata
- Authors
- Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M.
- Affiliations
- University of Oslo (NO)
- Odense University Hospital (DK)
- Haukeland University Hospital (NO)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-03-01
- Volume
- 58
- Issue
- 3
- Pages
- 527-535
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2646050
- OpenAlex
- W2110135879
- Cited by
- 73
- References
- 51
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 4
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- type 2 diabetes, skeletal muscle myotubes, fatty acid beta-oxidation, fatty acid oxidation, eicosapentaenoic acid, tetradecylthioacetic acid, palmitic acid, triglyceride accumulation, mitochondrial dysfunction, glucose oxidation, insulin resistance, acyl-CoA, fatty acid uptake, gene expression
- MeSH terms
- Uncoupling Protein 2, Fatty Acid Binding Protein 3, Carbon Dioxide, Carbon Radioisotopes, Carnitine O-Palmitoyltransferase, Diabetes Mellitus, Type 2, Fatty Acids, Glucose, Humans, Insulin, Ion Channels, Lipids, Oxidation-Reduction, Reference Values, Sulfides, Eicosapentaenoic Acid, Muscle Fibers, Skeletal, Oleic Acid, Palmitic Acid, Reverse Transcriptase Polymerase Chain Reaction, Mitochondrial Proteins, Myoblasts, Fatty Acid-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.